Home > > > > Report Detail

Global Biosimilar Monoclonal Antibodies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 07-Jan-2019
No. of pages: 128

A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal antibody is made so that it binds to only one substance to treat different types of cancer. There are several types of monoclonal antibodies that are being used to treat certain types of cancer. Laboratory production of monoclonal antibodies is produced from clones of only one cell which means that every monoclonal antibody produced by the cell is the same due to which they are called as biosimilar monoclonal antibodies. Each monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein they are targeting, hence different monoclonal antibodies are required to be made to target different types of cancer.

Scope of the Report:

This report focuses on the Biosimilar Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Biosimilar Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Pfizer, Inc.

- Novartis AG

- Reliance Life Sciences

- Allergan plc

- Coherus BioSciences, Inc.

- Biocon

- Dr. Reddy's Laboratories Ltd.

- Boehringer Ingelheim GmbH

- BioXpress Therapeutics SA

- Intas Pharmaceuticals Limited

- BIOCAD

- Genor BioPharma Co. Ltd

- Celltrion, Inc.

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Rituximab

- Infliximab

- Abciximab

- Trastuzumab

- Adalimumab

- Bevacizumab

Market Segment by Applications, can be divided into

- Oncology

- Chronic and Autoimmune Diseases

- Growth Hormone Deficiency

- Infectious Diseases

- Others

There are 15 Chapters to deeply display the global Biosimilar Monoclonal Antibodies market.

Chapter 1, to describe Biosimilar Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilar Monoclonal Antibodies, with sales, revenue, and price of Biosimilar Monoclonal Antibodies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar Monoclonal Antibodies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Biosimilar Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Biosimilar Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Biosimilar Monoclonal Antibodies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Biosimilar Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Rituximab
1.2.2 Infliximab
1.2.3 Abciximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Bevacizumab
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Chronic and Autoimmune Diseases
1.3.3 Growth Hormone Deficiency
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc.
2.1.1 Business Overview
2.1.2 Biosimilar Monoclonal Antibodies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Biosimilar Monoclonal Antibodies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Reliance Life Sciences
2.3.1 Business Overview
2.3.2 Biosimilar Monoclonal Antibodies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan plc
2.4.1 Business Overview
2.4.2 Biosimilar Monoclonal Antibodies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan plc Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Coherus BioSciences, Inc.
2.5.1 Business Overview
2.5.2 Biosimilar Monoclonal Antibodies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biocon
2.6.1 Business Overview
2.6.2 Biosimilar Monoclonal Antibodies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biocon Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Dr. Reddy's Laboratories Ltd.
2.7.1 Business Overview
2.7.2 Biosimilar Monoclonal Antibodies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim GmbH
2.8.1 Business Overview
2.8.2 Biosimilar Monoclonal Antibodies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 BioXpress Therapeutics SA
2.9.1 Business Overview
2.9.2 Biosimilar Monoclonal Antibodies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Intas Pharmaceuticals Limited
2.10.1 Business Overview
2.10.2 Biosimilar Monoclonal Antibodies Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 BIOCAD
2.11.1 Business Overview
2.11.2 Biosimilar Monoclonal Antibodies Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 BIOCAD Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Genor BioPharma Co. Ltd
2.12.1 Business Overview
2.12.2 Biosimilar Monoclonal Antibodies Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Genor BioPharma Co. Ltd Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Celltrion, Inc.
2.13.1 Business Overview
2.13.2 Biosimilar Monoclonal Antibodies Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Celltrion, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilar Monoclonal Antibodies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2017
3.3.2 Top 6 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biosimilar Monoclonal Antibodies Market Analysis by Regions
4.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2013-2018)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2013-2018)
4.2 North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.3 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.5 South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5 North America Biosimilar Monoclonal Antibodies by Countries
5.1 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
5.1.1 North America Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
5.1.2 North America Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
5.2 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.3 Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.4 Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6 Europe Biosimilar Monoclonal Antibodies by Countries
6.1 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
6.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
6.2 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.3 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.4 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.5 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.6 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biosimilar Monoclonal Antibodies by Countries
7.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
7.2 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.3 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.4 Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.5 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8 South America Biosimilar Monoclonal Antibodies by Countries
8.1 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
8.1.1 South America Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
8.1.2 South America Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.3 Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.4 Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biosimilar Monoclonal Antibodies by Countries
9.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.3 UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.4 Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.5 Nigeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.6 South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
10 Global Biosimilar Monoclonal Antibodies Market Segment by Type
10.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
10.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Rituximab Sales Growth and Price
10.2.1 Global Rituximab Sales Growth (2013-2018)
10.2.2 Global Rituximab Price (2013-2018)
10.3 Infliximab Sales Growth and Price
10.3.1 Global Infliximab Sales Growth (2013-2018)
10.3.2 Global Infliximab Price (2013-2018)
10.4 Abciximab Sales Growth and Price
10.4.1 Global Abciximab Sales Growth (2013-2018)
10.4.2 Global Abciximab Price (2013-2018)
10.5 Trastuzumab Sales Growth and Price
10.5.1 Global Trastuzumab Sales Growth (2013-2018)
10.5.2 Global Trastuzumab Price (2013-2018)
10.6 Adalimumab Sales Growth and Price
10.6.1 Global Adalimumab Sales Growth (2013-2018)
10.6.2 Global Adalimumab Price (2013-2018)
10.7 Bevacizumab Sales Growth and Price
10.7.1 Global Bevacizumab Sales Growth (2013-2018)
10.7.2 Global Bevacizumab Price (2013-2018)
11 Global Biosimilar Monoclonal Antibodies Market Segment by Application
11.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)
11.4 Growth Hormone Deficiency Sales Growth (2013-2018)
11.5 Infectious Diseases Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Biosimilar Monoclonal Antibodies Market Forecast by Regions (2018-2023)
12.2.1 North America Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.2 Europe Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.4 South America Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.3 Biosimilar Monoclonal Antibodies Market Forecast by Type (2018-2023)
12.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2018-2023)
12.3.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
12.4 Biosimilar Monoclonal Antibodies Market Forecast by Application (2018-2023)
12.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2018-2023)
12.4.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Biosimilar Monoclonal Antibodies Picture
Table Product Specifications of Biosimilar Monoclonal Antibodies
Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Types in 2017
Table Biosimilar Monoclonal Antibodies Types for Major Manufacturers
Figure Rituximab Picture
Figure Infliximab Picture
Figure Abciximab Picture
Figure Trastuzumab Picture
Figure Adalimumab Picture
Figure Bevacizumab Picture
Figure Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Chronic and Autoimmune Diseases Picture
Figure Growth Hormone Deficiency Picture
Figure Infectious Diseases Picture
Figure Others Picture
Figure United States Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure France Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure China Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure India Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc. Biosimilar Monoclonal Antibodies Type and Applications
Table Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Biosimilar Monoclonal Antibodies Type and Applications
Table Novartis AG Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Reliance Life Sciences Basic Information, Manufacturing Base and Competitors
Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Type and Applications
Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan plc Basic Information, Manufacturing Base and Competitors
Table Allergan plc Biosimilar Monoclonal Antibodies Type and Applications
Table Allergan plc Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Coherus BioSciences, Inc. Basic Information, Manufacturing Base and Competitors
Table Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Type and Applications
Table Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Biosimilar Monoclonal Antibodies Type and Applications
Table Biocon Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dr. Reddy's Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Type and Applications
Table Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Type and Applications
Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BioXpress Therapeutics SA Basic Information, Manufacturing Base and Competitors
Table BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Type and Applications
Table BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Intas Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Type and Applications
Table Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BIOCAD Basic Information, Manufacturing Base and Competitors
Table BIOCAD Biosimilar Monoclonal Antibodies Type and Applications
Table BIOCAD Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genor BioPharma Co. Ltd Basic Information, Manufacturing Base and Competitors
Table Genor BioPharma Co. Ltd Biosimilar Monoclonal Antibodies Type and Applications
Table Genor BioPharma Co. Ltd Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celltrion, Inc. Basic Information, Manufacturing Base and Competitors
Table Celltrion, Inc. Biosimilar Monoclonal Antibodies Type and Applications
Table Celltrion, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2016-2017)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer in 2016
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer in 2017
Table Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2016-2017)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2016
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2017
Figure Top 3 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales by Regions (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Revenue by Regions (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2013
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2017
Figure North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure North America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table North America Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2013
Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2017
Table North America Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
Table North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Europe Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Table Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2016
Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries 2017
Table Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries 2017
Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table South America Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
Table South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2017
Table South America Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
Table South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries in 2017
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2013
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure Nigeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Figure South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales by Type (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Type (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Revenue by Type (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
Figure Global Rituximab Sales Growth (2013-2018)
Figure Global Rituximab Price (2013-2018)
Figure Global Infliximab Sales Growth (2013-2018)
Figure Global Infliximab Price (2013-2018)
Figure Global Abciximab Sales Growth (2013-2018)
Figure Global Abciximab Price (2013-2018)
Figure Global Trastuzumab Sales Growth (2013-2018)
Figure Global Trastuzumab Price (2013-2018)
Figure Global Adalimumab Sales Growth (2013-2018)
Figure Global Adalimumab Price (2013-2018)
Figure Global Bevacizumab Sales Growth (2013-2018)
Figure Global Bevacizumab Price (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales by Application (2013-2018)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Application (2013-2018)
Figure Global Chronic and Autoimmune Diseases Sales Growth (2013-2018)
Figure Global Growth Hormone Deficiency Sales Growth (2013-2018)
Figure Global Infectious Diseases Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Regions (2018-2023)
Figure North America Sales Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
Figure Europe Sales Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
Figure Asia-Pacific Sales Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
Figure South America Sales Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
Figure Middle East and Africa Sales Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs